Virological surveillance on humans, i.e., tracking of prevailing genotypes/serotypes

Capacity for virological surveillance on human specimens (ref Q19)

Country

RT-PCR

Serological testing

Anguilla

Antigua and Barbuda

Argentina

X

X

Aruba

Bahamas

X

X

Barbados

X

X

Belize

X

X

Bermuda

X

X

Bolivia (Plurinational State of)

X

X

Bonaire

Brazil

X

X

British Virgin Islands

Canada

X

X

Cayman Islands

Chile

X

X

Colombia

X

X

Costa Rica

X

X

Cuba

X

X

Curaçao

Dominica

X

X

Dominican Republic

X

X

Ecuador

X

X

El Salvador

X

X

French Guiana

X

X

Grenada

Guadeloupe

Guatemala

X

X

Guyana

X

X

Haiti

X

X

Honduras

X

X

Jamaica

X

X

Martinique

Mexico

X

X

Montserrat

Nicaragua

X

X

Panama

X

X

Paraguay

X

X

Peru

X

X

Puerto Rico

X

X

Saint Barthélemy

Saint Kitts and Nevis

Saint Lucia

X

Saint Martin

Saint Vincent and the Grenadines

Sint Maarten

Suriname

X

X

Trinidad and Tobago

X

X

Turks and Caicos Islands

United States Virgin Islands

United States of America

X

X

Uruguay

X

X

Venezuela (Bolivarian Republic of)

X

X

No countries reported the use of Virus isolation, Other nucleic acid tests.